Overview

The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The role of Helicobacter pylori(HP)in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) is controversial.
Phase:
Phase 2
Details
Lead Sponsor:
Tehran University of Medical Sciences
Treatments:
Amoxicillin
Azithromycin
Bismuth
Bismuth tripotassium dicitrate
Omeprazole